Smoking cessation in a community pharmacy: Preliminary results of a pharmaceutical care programme;Cesación tabáquica en farmacia comunitaria: Resultados preliminares de un programa de atención farmacéutica

Vitae

Volumn 22, Issue 1, 2015, Pages 42-46

  Condinho, Mónica ^a,b   Fernández Llimos, Fernando ^c   Figueiredo, Isabel V ^a,d   Sinogas, Carlos ^e  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b ACF Acompanhamento Farmacoterapêutico   (Portugal)

^c RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e UNIVERSITY OF ÉVORA   (Portugal)

Author keywords

Community pharmacy; Pharmaceutical care; Pharmacist; Smoking cessation

Indexed keywords

AMFEBUTAMONE; ANXIOLYTIC AGENT; DRUGS USED IN THE TREATMENT OF ADDICTION; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; VARENICLINE;

ADULT; ANXIETY; ARTICLE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; NICOTINE REPLACEMENT THERAPY; OBESITY; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PHYTOTHERAPY; PORTUGAL; RETROSPECTIVE STUDY; SMOKING CESSATION PROGRAM; SPIROMETRY; TOBACCO DEPENDENCE;

NICOTIANA TABACUM;

EID: 84938349976     PISSN: 01214004     EISSN: 21452660     Source Type: Journal    
DOI: 10.17533/udea.vitae.v22n1a05     Document Type: Article

References (13)

1. World Health Organisation. Tobacco – Fact sheet nº 339. Updated May 2014. Available on http://www.who.int/mediacentre factsheets/fs339/en/ (Accessed 4 October 2014).
2. World Health Organisation. WHO global report: mortality attributable to tobacco. 2012. Available on http://whqlibdoc.who. int/publications/2012/9789241564434_eng.pdf?ua=1 (Accessed 4 October 2014).
3. Direção-Geral da Saúde. Portugal: Prevenção e Controlo do Tabagismo em Números - 2013. Programa Nacional para a Prevenção e Controlo do Tabagismo. 2013. Available on http://www.dgs.pt/estatisticas-de-saude/estatisticas-de-saude/publicacoes/portugal-prevencao-e-controlo-do-tabagismo-emnumeros-2013.aspx (Accessed 5 October 2014).
4. Saba M, Diep J, Saini B, Dhippayom T. Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy. J Clin Pharm Ther 2014; 39(3):240-7.
5. Costello M, Sproule B, Victor J, Leatherdale S, Zawertailo L, Selby P. Effectiveness of pharmacist counselling combined with nicotine replacement therapy: a pragmatic randomised trial with 6,987 smokers. Cancer Causes Control 2011; 22(2):167-80.
6. Dent L, Harris K, Noonan C. Randomized trial assessing the effectiveness of a pharmacist-delivered programme for smoking cessation. Ann Pharmacother 2009; 43(2):194-201.
7. Direção-Geral da Saúde. Cessação tabágica. Programa-tipo de actuação. Gradiva. 2007. Available on http://www.dgs.pt/upload/ membro.id/ficheiros/i009774.pdf (Accessed 28 November 2014).
8. Richmond RI, Kehoe LA, Webster IW. Multivariate models for predicting abstention following intervention to stop smoking by general practitioners. Addiction. 1993; 88(8):1127-35.
9. Ferreira PL, Quintal C, Lopes I, Taveira N. Teste de dependência à nicotina: validação linguística e psicométrica do teste de Fagerström. Rev Port Saúde Pública. 2009;27(2):37-56.
10. Machado A, Nicolau R, Dias C. Consumo de tabaco na população portuguesa retratado pelo Inquérito Nacional de Saúde (2005/2006). Rev Port Pneumol 2009; XV(6):1005-27.
11. Aguiar M, Todo-Bom F, Felizardo M, Caeiro F, Sotto-Mayor R, Bugalho de Almeida A. Casuística de quatro anos de um consulta de apoio ao fumador. Rev Port Pneumol 2009; XV:179-97.
12. Bauld L, Boyd K, Briggs A, Chesterman J, Ferguson J, Judge K, et al. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine Tob Res 2011; 13(2):135-45.
13. Khan N, Anderson J, Du J, Tinker D, Bachyrycz A, Namdar R. Smoking cessation and its predictors: results from a communitybased pharmacy tobacco cessation programme in New Mexico. Ann Pharmacother 2012; 46(9):1198-204.